{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T17:24:06Z","timestamp":1770485046141,"version":"3.49.0"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1097\/gme.0b013e318291ef83","type":"journal-article","created":{"date-parts":[[2013,5,14]],"date-time":"2013-05-14T15:01:39Z","timestamp":1368543699000},"page":"596-597","source":"Crossref","is-referenced-by-count":5,"title":["Postmenopausal dyspareunia"],"prefix":"10.1097","volume":"20","author":[{"given":"Steven R.","family":"Goldstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-3-20210211","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/01.gme.0000222332.31101.42","article-title":"Not all SERMs are created equal.","volume":"13","author":"Goldstein","year":"2006","journal-title":"Menopause"},{"key":"R3-3-20210211","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/gme.0b013e318223bbf4","article-title":"Gynecologic effects of arzoxifene in postmenopausal women with osteoporosis or low bone mass.","volume":"19","author":"Goldstein","year":"2012","journal-title":"Menopause"},{"key":"R4-3-20210211","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.","volume":"90","author":"Fisher","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"R5-3-20210211","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0002-9378(94)70209-8","article-title":"Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen.","volume":"170","author":"Goldstein","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"R6-3-20210211","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1067\/mob.2002.123938","article-title":"Adverse events that are associated with the selective estrogen receptor modulator levormeloxifene in an aborted phase III osteoporosis treatment study.","volume":"187","author":"Goldstein","year":"2002","journal-title":"J Obstet Gynecol"},{"key":"R7-3-20210211","first-page":"95","article-title":"A 12-month comparative study of raloxifene, estrogen, and placebo on the postmenopausal endometrium.","volume":"95","author":"Goldstein","year":"2000","journal-title":"Obstet Gynecol"},{"key":"R8-3-20210211","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/cmt.6.3.248.256","article-title":"Effect of raloxifene on sexual function in postmenopausal women.","volume":"6","author":"Kessel","year":"2003","journal-title":"Climacteric"},{"key":"R9-3-20210211","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/gme.0b013e3181e84bb4","article-title":"Postmenopausal Evaluation and Risk Reduction with Lasofoxifene (PEARL) trial: 5-year gynecological outcomes.","volume":"18","author":"Goldstein","year":"2011","journal-title":"Menopause"},{"key":"R10-3-20210211","first-page":"77","article-title":"Endometrial safety profile of ospemifene 60 mg when used for long-term treatment of vulvar and vaginal atrophy for up to 1 year.","volume":"14","author":"Goldstein","year":"2011","journal-title":"Climacteric"},{"key":"R11-3-20210211","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1001\/jama.281.23.2189","article-title":"The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.","volume":"281","author":"Cummings","year":"1999","journal-title":"JAMA"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GME.0b013e318291ef83","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:42:21Z","timestamp":1620952941000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042192-201306000-00003"}},"subtitle":["has the Food and Drug Administration really helped?"],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e318291ef83","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}